Published in QJM on March 10, 2009
Left superior vena cava persistence in patients undergoing pacemaker or cardioverter-defibrillator implantation: a 10-year experience. Chest (2001) 5.12
Selective expression of an interleukin-12 receptor component by human T helper 1 cells. J Exp Med (1997) 3.57
Transcript imaging of the development of human T helper cells using oligonucleotide arrays. Nat Genet (2000) 2.71
Relationship of serum C3 to fasting insulin, risk factors and previous ischaemic events in middle-aged men. Eur Heart J (2000) 1.73
The role of Stat4 in species-specific regulation of Th cell development by type I IFNs. J Immunol (1998) 1.65
Neurophysiological effects of mobile phone electromagnetic fields on humans: a comprehensive review. Bioelectromagnetics (2007) 1.64
Nitroxyl anion exerts redox-sensitive positive cardiac inotropy in vivo by calcitonin gene-related peptide signaling. Proc Natl Acad Sci U S A (2001) 1.63
Prognosis of asymptomatic patients with hypertrophic cardiomyopathy and nonsustained ventricular tachycardia. Circulation (1994) 1.61
Gluten sensitivity and 'normal' histology: is the intestinal mucosa really normal? Dig Liver Dis (2003) 1.60
Non-invasive evaluation of the myocardial substrate of cardiac amyloidosis by gadolinium cardiac magnetic resonance. Heart (2005) 1.57
Wide spectrum of presentation and variable outcomes of isolated left ventricular non-compaction. Heart (2006) 1.53
Long term results of a randomized study performed by Intergruppo Italiano Linfomi comparing Mini-CEOP vs P-VEBEC in elderly patients with diffuse large B-cell lymphoma. Leuk Lymphoma (2007) 1.51
A multicentre, double-blind randomized crossover comparative study on the efficacy and safety of dofetilide vs sotalol in patients with inducible sustained ventricular tachycardia and ischaemic heart disease. Eur Heart J (2001) 1.46
Malignant vasovagal syncope: a randomised trial of metoprolol and clonidine. Heart (1997) 1.42
Coronary stenting with the half (disarticulated) Palmaz-Schatz stent: immediate results and six-month follow-up. Cathet Cardiovasc Diagn (1997) 1.40
Stage-modified international prognostic index effectively predicts clinical outcome of localized primary gastric diffuse large B-cell lymphoma. International Extranodal Lymphoma Study Group (IELSG) Ann Oncol (1999) 1.24
Antibodies to the IL-12 receptor beta 2 chain mark human Th1 but not Th2 cells in vitro and in vivo. J Immunol (1999) 1.15
Nightmares and sleep disturbances with simvastatin and metoprolol. Ann Pharmacother (2001) 1.12
Evidence of a partial escape of renin-angiotensin-aldosterone blockade in patients with acute myocardial infarction treated with ACE inhibitors. J Clin Pharmacol (1993) 1.10
A randomized placebo-controlled trial of fluvastatin for prevention of restenosis after successful coronary balloon angioplasty; final results of the fluvastatin angiographic restenosis (FLARE) trial. Eur Heart J (1999) 1.07
A novel Alu-like element rearranged in the dystrophin gene causes a splicing mutation in a family with X-linked dilated cardiomyopathy. Am J Hum Genet (1998) 1.06
Topographical distribution of spindles: variations between and within nrem sleep cycles. Sleep Res Online (2000) 1.05
The spontaneous K-complex during stage 2 sleep: is it the 'forerunner' of delta waves? Neurosci Lett (2000) 1.05
Opposite effects of interleukin 10 common gene polymorphisms in cardiovascular diseases and in successful ageing: genetic background of male centenarians is protective against coronary heart disease. J Med Genet (2004) 1.04
Pulmonary arterial hypertension associated to connective tissue diseases. Lupus (2005) 1.03
The boundary between wakefulness and sleep: quantitative electroencephalographic changes during the sleep onset period. Neuroscience (2001) 0.99
Dynamic electrophysiological behavior of human atria during paroxysmal atrial fibrillation. Circulation (1995) 0.99
Visual search performance across 40 h of continuous wakefulness: Measures of speed and accuracy and relation with oculomotor performance. Physiol Behav (2001) 0.99
Benefits in projected pacemaker longevity and in pacing related costs conferred by automatic threshold tracking. Pacing Clin Electrophysiol (2000) 0.99
Evaluation of the pulse-contour method of determining stroke volume in man. Circulation (1972) 0.98
Is the brain influenced by a phone call? An EEG study of resting wakefulness. Neurosci Res (2005) 0.97
Transvenous low energy internal cardioversion for atrial fibrillation: a review of clinical applications and future developments. Pacing Clin Electrophysiol (2001) 0.96
Selective slow-wave sleep (SWS) deprivation and SWS rebound: do we need a fixed SWS amount per night? Sleep Res Online (1999) 0.96
AF burden is important - fact or fiction? Int J Clin Pract (2014) 0.96
Oral propafenone to convert recent-onset atrial fibrillation in patients with and without underlying heart disease. A randomized, controlled trial. Ann Intern Med (1997) 0.94
Role of pharmacologic tests in the treatment of primary pulmonary hypertension. Am J Cardiol (1995) 0.92
Psychosocial factors and clinical evolution in HIV-1 infection: a longitudinal study. J Psychosom Res (1993) 0.92
Selective slow-wave sleep deprivation and time-of-night effects on cognitive performance upon awakening. Psychophysiology (2000) 0.92
Clinical value of multidetector CT coronary angiography as a preoperative screening test before non-coronary cardiac surgery. Heart (2006) 0.92
Colonic disease in cirrhotic patients with portal hypertension: an endoscopic and clinical evaluation. J Clin Gastroenterol (1998) 0.91
Rearrangements of bcl-6, bcl-2, c-myc and 6q deletion in B-diffuse large-cell lymphoma: clinical relevance in 71 patients. Ann Oncol (1998) 0.91
Conversion of recent-onset atrial fibrillation to sinus rhythm: effects of different drug protocols. Pacing Clin Electrophysiol (1998) 0.91
Enhanced thrombolytic efficacy and reduction of infarct size by simultaneous infusion of streptokinase and heparin. Br Heart J (1990) 0.90
Assessing vigilance through a brief pencil and paper letter cancellation task (LCT): effects of one night of sleep deprivation and of the time of day. Ergonomics (1997) 0.90
EEG arousals in normal sleep: variations induced by total and selective slow-wave sleep deprivation. Sleep (2001) 0.88
Medical therapy of pulmonary hypertension. The prostacyclins. Clin Chest Med (2001) 0.88
Liver targeting of antiviral nucleoside analogues through the asialoglycoprotein receptor. J Viral Hepat (1997) 0.87
Point mutations of the BCL-6 gene: clinical and prognostic correlation in B-diffuse large cell lymphoma. Leukemia (2002) 0.87
Effects of different sleep reductions on daytime sleepiness. Sleep (1999) 0.86
Effect of slow-wave sleep deprivation on topographical distribution of spindles. Behav Brain Res (2000) 0.86
Oculomotor impairment after 1 night of total sleep deprivation: a dissociation between measures of speed and accuracy. Clin Neurophysiol (2000) 0.86
Variations in sleep mentation as a function of time of night. Int J Neurosci (1996) 0.86
Interplay between methylenetetrahydrofolate reductase gene polymorphism 677C-->T and serum folate levels in determining hyperhomocysteinemia in heart transplant recipients. J Heart Lung Transplant (2001) 0.85
Primary pulmonary hypertension: insights into pathogenesis from epidemiology. Chest (1998) 0.85
Autocrine and intracrine signaling for cardiogenesis in embryonic stem cells: a clue for the development of novel differentiating agents. Handb Exp Pharmacol (2006) 0.85
On the value of the activated clotting time for monitoring heparin therapy in acute coronary syndromes. Am J Cardiol (1993) 0.85
Interleukin-6 gene polymorphism is an age-dependent risk factor for myocardial infarction in men. Int J Immunogenet (2005) 0.84
A virus-induced non-virion antigen specific for transformation at the surface of RSV-transformed fibroblasts. Nature (1978) 0.84
Improved results with pericystectomy in normothermic ischemia for hepatic hydatidosis. Surg Gynecol Obstet (1986) 0.84
Sleepiness: evaluating and quantifying methods. Int J Psychophysiol (2001) 0.84
Efficacy and tolerability in fully conscious patients of transvenous low-energy internal atrial cardioversion for atrial fibrillation. Am J Cardiol (1998) 0.84
Psychological evaluation after cardiac transplantation: the integration of different criteria. Psychother Psychosom (2001) 0.83
Leukocyte subsets and cortisol serum levels in patients with migraine without aura and chronic tension-type headache. Cephalalgia (1994) 0.83
Atrial fibrillation recurrence after internal cardioversion: prognostic importance of electrophysiological parameters. Heart (2002) 0.83
Low energy internal atrial cardioversion in atrial fibrillation lasting more than a year. Pacing Clin Electrophysiol (1999) 0.83
Genetic heterogeneity of hypertrophic cardiomyopathy. Int J Cardiol (1985) 0.82
The new clinical trials on pharmacological treatment in pulmonary arterial hypertension. Eur Respir J (2002) 0.82
Electrophysiological effects of flecainide and propafenone on atrial fibrillation cycle and relation with arrhythmia termination. Heart (1999) 0.82
Favorable effects of flecainide in transvenous internal cardioversion of atrial fibrillation. J Am Coll Cardiol (1999) 0.82
Electrical cardioversion for persistent atrial fibrillation or atrial flutter in clinical practice: predictors of long-term outcome. Int J Clin Pract (2007) 0.81
Differential effect of everolimus on progression of early and late cardiac allograft vasculopathy in current clinical practice. Am J Transplant (2013) 0.81
Effects of L-NG-nitro arginine on cholinergic transmission in the gastric muscle of the rabbit. Neuroreport (1993) 0.81
The effects of slow-wave sleep (SWS) deprivation and time of night on behavioral performance upon awakening. Physiol Behav (2000) 0.81
Ultrastructural lesions in the small bowel of patients with cystic fibrosis. Pediatr Res (1998) 0.81
Results of coronary stenting for unstable versus stable angina pectoris. Am J Cardiol (1997) 0.81
Reduced oxidative activity of circulating neutrophils in patients after myocardial infarction. Cell Biochem Funct (1990) 0.81
Comparison of efficacy of low molecular weight heparin (parnaparin) with that of unfractionated heparin in the presence of activated platelets in healthy subjects. Am J Cardiol (1993) 0.81
Long term outcome in patients with silent versus symptomatic ischaemia during dobutamine stress echocardiography. Heart (2005) 0.81
Benefit of adding low molecular weight heparin to the conventional treatment of stable angina pectoris. A double-blind, randomized, placebo-controlled trial. Circulation (1993) 0.80
Evidence for a membrane carrier molecule common to embryonal and tumour-specific antigenic determinants expressed by a mouse transplantable tumour. Immunology (1975) 0.80
Comparative haemodynamic effects of transdermal vs intravenous nitroglycerin in acute myocardial infarction with elevated pulmonary artery wedge pressure. Eur Heart J (1990) 0.79
Predictive value of the early response to chemotherapy in high-risk stages II and III Hodgkin's disease. Cancer (1987) 0.79
[Measuring the positive dimensions among health care workers: a contribution to the Italian validation of the UWES--Utrecht Work Engagement Scale]. G Ital Med Lav Ergon (2008) 0.79
Hepatotropic conjugate of adenine arabinoside monophosphate with lactosaminated poly-L-lysine. Synthesis of the carrier and pharmacological properties of the conjugate. J Hepatol (1997) 0.79